Global EconomyEconomic Times•1 min read•10/6/2026 (2h ago)

Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbath

Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbath
60-Word AI Digest

In an unprecedented downturn, the Nifty has faced its longest losing streak in 25 years, sliding for over eight weeks as foreign investors withdrew significant funds from Indian equities. Despite this market decline in September, seven stocks, led by Kotak Mahindra Bank and Dr Reddy's Laboratories, demonstrated resilience. Particularly, Kotak Mahindra Bank's performance is linked to...

Key Takeaways

  • In an unprecedented downturn, the Nifty has faced its longest losing streak in 25 years, sliding for over eight weeks as foreign investors withdrew significant funds from Indian equities.
  • Despite this market decline in September, seven stocks, led by Kotak Mahindra Bank and Dr Reddy's Laboratories, demonstrated resilience.
  • Particularly, Kotak Mahindra Bank's performance is linked to robust analyst endorsements and optimism surrounding the banking sector's recovery.

In an unprecedented downturn, the Nifty has faced its longest losing streak in 25 years, sliding for over eight weeks as foreign investors withdrew significant funds from Indian equities. Despite this market decline in September, seven stocks, led by Kotak Mahindra Bank and Dr Reddy's Laboratories, demonstrated resilience. Particularly, Kotak Mahindra Bank's performance is linked to robust analyst endorsements and optimism surrounding the banking sector's recovery.

Original Publisher Attribution

This summary was curated from Economic Times.

Read Original on Economic Times
Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbath — Loop60